Back
Recursion Pharmaceuticals Vs. Kyndryl Holdings Industry Stock Comparison
Sell
44
RXRX
Recursion Pharmaceuticals
Last Price:
5.70
Seasonality Move:
6.36%
Sell
22
KD
Kyndryl Holdings
Last Price:
33.07
Seasonality Move:
21.65%
Sell
44
Recursion Pharmaceuticals (RXRX)
is a Sell
Is Recursion Pharmaceuticals a Buy, Sell or Hold?
- The current Recursion Pharmaceuticals [RXRX] share price is $5.70. The Score for RXRX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- RXRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
22
Kyndryl Holdings (KD)
is a Sell
Is Kyndryl Holdings a Buy, Sell or Hold?
- The current Kyndryl Holdings [KD] share price is $33.05. The Score for KD is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
- KD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RXRX Stock Price Chart
What is Recursion Pharmaceuticals's stock price today?
-
The Recursion Pharmaceuticals share price today is $5.70
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RXRX is experiencing slight selling pressure.
KD Stock Price Chart
What is Kyndryl Holdings's stock price today?
-
The Kyndryl Holdings share price today is $33.05
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KD is experiencing slight selling pressure.
RXRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.19 | Sell |
| Relative Strength Index (14 RSI): | 36.56 | Sell |
| Chaikin Money Flow: | -6628710 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.12 - 7.14) | Sell |
| Bollinger Bands (100): | (6.24 - 7.62) | Sell |
KD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.81 | Buy |
| Relative Strength Index (14 RSI): | 84.9 | Buy |
| Chaikin Money Flow: | -44447 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.34 - 29.08) | Buy |
| Bollinger Bands (100): | (22.56 - 26.92) | Buy |
RXRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.28 | Sell |
| 20-day SMA: | 6.66 | Sell |
| 50-day SMA: | 6.62 | Sell |
| 200-day SMA: | 8.32 | Sell |
| 8-day EMA: | 6.19 | Sell |
| 20-day EMA: | 6.49 | Sell |
| 50-day EMA: | 6.67 | Sell |
| 200-day EMA: | 7.68 | Sell |
KD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.38 | Buy |
| 20-day SMA: | 26.71 | Buy |
| 50-day SMA: | 24.99 | Buy |
| 200-day SMA: | 24.01 | Buy |
| 8-day EMA: | 29.79 | Buy |
| 20-day EMA: | 27.67 | Buy |
| 50-day EMA: | 25.83 | Buy |
| 200-day EMA: | 23.56 | Buy |
Recursion Pharmaceuticals Earnings Growth & RXRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and a decrease next year of $0.11 per share.
Kyndryl Holdings Earnings Growth & KD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.37 per share, and an increase next year of $1.26 per share.
Recursion Pharmaceuticals Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kyndryl Holdings Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||